CN104435710A - A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method - Google Patents
A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method Download PDFInfo
- Publication number
- CN104435710A CN104435710A CN201410688245.8A CN201410688245A CN104435710A CN 104435710 A CN104435710 A CN 104435710A CN 201410688245 A CN201410688245 A CN 201410688245A CN 104435710 A CN104435710 A CN 104435710A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- disintegrating agent
- radix
- liver
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 42
- 210000004185 liver Anatomy 0.000 title claims abstract description 20
- 210000000952 spleen Anatomy 0.000 title claims abstract description 18
- 239000007919 dispersible tablet Substances 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 238000004806 packaging method and process Methods 0.000 claims abstract description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 31
- 239000000284 extract Substances 0.000 claims description 28
- 239000000945 filler Substances 0.000 claims description 18
- 239000000314 lubricant Substances 0.000 claims description 18
- 239000000080 wetting agent Substances 0.000 claims description 18
- 239000002994 raw material Substances 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 10
- 239000010231 banlangen Substances 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 9
- 239000000203 mixture Substances 0.000 claims description 8
- 239000000047 product Substances 0.000 claims description 7
- 238000005728 strengthening Methods 0.000 claims description 7
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 239000009636 Huang Qi Substances 0.000 claims description 4
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 4
- 238000005469 granulation Methods 0.000 claims description 4
- 230000003179 granulation Effects 0.000 claims description 4
- 239000012535 impurity Substances 0.000 claims description 4
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 3
- 229920000881 Modified starch Polymers 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 3
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 3
- 235000010357 aspartame Nutrition 0.000 claims description 3
- 239000000605 aspartame Substances 0.000 claims description 3
- 229960003438 aspartame Drugs 0.000 claims description 3
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 claims description 3
- 239000000706 filtrate Substances 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 3
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 claims description 3
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 claims description 3
- 239000000377 silicon dioxide Substances 0.000 claims description 3
- 235000012239 silicon dioxide Nutrition 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims 5
- -1 correctives Substances 0.000 claims 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- 239000004141 Sodium laurylsulphate Substances 0.000 claims 1
- 230000001476 alcoholic effect Effects 0.000 claims 1
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 1
- 238000004132 cross linking Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 235000019359 magnesium stearate Nutrition 0.000 claims 1
- 239000007968 orange flavor Substances 0.000 claims 1
- 239000001253 polyvinylpolypyrrolidone Substances 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims 1
- 208000006454 hepatitis Diseases 0.000 abstract description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 230000001154 acute effect Effects 0.000 abstract description 5
- 229940079593 drug Drugs 0.000 abstract description 5
- 206010008909 Chronic Hepatitis Diseases 0.000 abstract description 4
- 208000019425 cirrhosis of liver Diseases 0.000 abstract description 3
- 238000003860 storage Methods 0.000 abstract description 3
- 238000004090 dissolution Methods 0.000 abstract description 2
- 238000009826 distribution Methods 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 230000009747 swallowing Effects 0.000 abstract description 2
- 239000007884 disintegrant Substances 0.000 description 10
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 241000132012 Atractylodes Species 0.000 description 7
- 241000202726 Bupleurum Species 0.000 description 7
- 241000756042 Polygonatum Species 0.000 description 7
- 240000001341 Reynoutria japonica Species 0.000 description 7
- 235000018167 Reynoutria japonica Nutrition 0.000 description 7
- 241000304195 Salvia miltiorrhiza Species 0.000 description 7
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 7
- 235000008422 Schisandra chinensis Nutrition 0.000 description 7
- 239000000796 flavoring agent Substances 0.000 description 7
- 235000013355 food flavoring agent Nutrition 0.000 description 7
- 241000092665 Atractylodes macrocephala Species 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 6
- 241000157835 Gardenia Species 0.000 description 6
- 241001071795 Gentiana Species 0.000 description 6
- 206010023126 Jaundice Diseases 0.000 description 6
- 208000002193 Pain Diseases 0.000 description 6
- 244000197580 Poria cocos Species 0.000 description 6
- 235000008599 Poria cocos Nutrition 0.000 description 6
- 235000006533 astragalus Nutrition 0.000 description 6
- 208000012287 Prolapse Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 241000045403 Astragalus propinquus Species 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 240000006079 Schisandra chinensis Species 0.000 description 4
- 239000012141 concentrate Substances 0.000 description 4
- 208000001848 dysentery Diseases 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 3
- 241000207199 Citrus Species 0.000 description 3
- 244000183685 Citrus aurantium Species 0.000 description 3
- 235000007716 Citrus aurantium Nutrition 0.000 description 3
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 3
- 235000016646 Citrus taiwanica Nutrition 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 206010014596 Encephalitis Japanese B Diseases 0.000 description 3
- 201000005807 Japanese encephalitis Diseases 0.000 description 3
- 241000710842 Japanese encephalitis virus Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 206010068319 Oropharyngeal pain Diseases 0.000 description 3
- 206010033557 Palpitations Diseases 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 241000972672 Phellodendron Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 241000736075 Schisandra Species 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 210000000436 anus Anatomy 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 235000020971 citrus fruits Nutrition 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 230000008673 vomiting Effects 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241001061264 Astragalus Species 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008469 Chest discomfort Diseases 0.000 description 2
- 240000002319 Citrus sinensis Species 0.000 description 2
- 235000005976 Citrus sinensis Nutrition 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 229920002785 Croscarmellose sodium Polymers 0.000 description 2
- 206010011878 Deafness Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019799 Hepatitis viral Diseases 0.000 description 2
- 235000008586 Hovenia Nutrition 0.000 description 2
- 241000405398 Hovenia Species 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000005647 Mumps Diseases 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 206010059013 Nocturnal emission Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 206010000059 abdominal discomfort Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000003756 cervix mucus Anatomy 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 229960004106 citric acid Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 229960001681 croscarmellose sodium Drugs 0.000 description 2
- 229960000913 crospovidone Drugs 0.000 description 2
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 231100000895 deafness Toxicity 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000016354 hearing loss disease Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000001055 magnesium Nutrition 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 208000010805 mumps infectious disease Diseases 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical group CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000008109 sodium starch glycolate Substances 0.000 description 2
- 229920003109 sodium starch glycolate Polymers 0.000 description 2
- 229940079832 sodium starch glycolate Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940013618 stevioside Drugs 0.000 description 2
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 2
- 235000019202 steviosides Nutrition 0.000 description 2
- 210000004233 talus Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 206010046901 vaginal discharge Diseases 0.000 description 2
- 201000001862 viral hepatitis Diseases 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010006002 Bone pain Diseases 0.000 description 1
- 206010006895 Cachexia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010015946 Eye irritation Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 206010018612 Gonorrhoea Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019705 Hepatic pain Diseases 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 206010019842 Hepatomegaly Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010031252 Osteomyelitis Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010041497 Spermatorrhoea Diseases 0.000 description 1
- 208000010040 Sprains and Strains Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 208000026500 emaciation Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 208000001786 gonorrhea Diseases 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 238000009169 immunotherapy Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 208000013465 muscle pain Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 201000001474 proteinuria Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了 一种疏肝健脾中药分散片及其制作方法, 由中药提取物、填充剂、内加崩解剂、外加崩解剂、矫味剂、润湿剂、润滑剂制成,本发明所述的分散片,具有清热解毒,疏肝健脾的功效,用于急、慢性肝炎,早期肝硬化的患者,其溶解性、分散性良好,溶出度高,生物利用度好,体内分布迅速,质量稳定,口感好,服用方便,可吞服,咀嚼,含 吮 或用水分散后服用,更适合老人和吞服困难的患者,具有药物稳定性好,包装,运输,贮藏方便等优点,其制备方法简单易行,适用于工业生产。 The invention discloses a dispersible tablet of traditional Chinese medicine for soothing the liver and invigorating the spleen and a preparation method thereof. The dispersible tablet of the present invention has the effects of clearing heat and detoxifying, soothing the liver and invigorating the spleen, and is used for patients with acute and chronic hepatitis and early liver cirrhosis. It has good solubility and dispersibility, high dissolution rate, and good bioavailability. Rapid distribution, stable quality, good taste, easy to take, can be swallowed, chewed, sucked or dispersed with water, more suitable for the elderly and patients with difficulty in swallowing, has the advantages of good drug stability, convenient packaging, transportation and storage, etc. , and its preparation method is simple and feasible, and is suitable for industrial production.
Description
技术领域 technical field
本发明属于制药技术领域,具体涉及一种疏肝健脾中药分散片及其制备方法。The invention belongs to the technical field of pharmacy, and in particular relates to a dispersible tablet of traditional Chinese medicine for soothing the liver and invigorating the spleen and a preparation method thereof.
背景技术 Background technique
病毒性肝炎是由多种肝炎病毒引起的以肝脏病变为主的一种传染病。是一种常见的、多发的、严重危害人们生命健康的传染病。其中以乙、丙型肝炎危害最大。临床上以食欲减退、恶心、上腹部不适、肝区痛、乏力为主要表现。部分病人可有黄疸发热和肝大伴有肝功能损害。有些病人可慢性化,甚至发展成肝硬化,少数可发展为肝癌。Viral hepatitis is an infectious disease mainly caused by liver lesions caused by a variety of hepatitis viruses. It is a common, frequently-occurring infectious disease that seriously endangers people's lives and health. Among them, hepatitis B and C are the most harmful. Clinically, the main manifestations are loss of appetite, nausea, upper abdominal discomfort, pain in the liver area, and fatigue. Some patients may have jaundice, fever and hepatomegaly with liver function damage. Some patients can become chronic, and even develop into liver cirrhosis, and a few can develop into liver cancer.
中医药治疗急、慢性肝炎有其独到特色,能明显改善病人的临床症状和体征,近年来的研究表明,采用中西药结合治疗急性肝炎均明显优于单纯西药治疗,对于急、慢性病毒肝炎,抑制病毒复制的作用故调整免疫治疗是一重要方向,充分利用中医辩证施治,达到疏肝理气,健脾和中,活血解毒作用,中药治疗,其在抗病毒、退黄降酶、减轻消化道症状、改善病人的体征等方面,都具有明显效果,使大多数患者都获得了较好疗效。The treatment of acute and chronic hepatitis with traditional Chinese medicine has its own unique characteristics, which can significantly improve the clinical symptoms and signs of patients. Recent studies have shown that the combination of Chinese and Western medicine in the treatment of acute hepatitis is significantly better than that of Western medicine alone. For acute and chronic viral hepatitis, Inhibiting the effect of virus replication, adjusting immunotherapy is an important direction. Make full use of TCM dialectical treatment to soothe the liver and regulate qi, invigorate the spleen and harmonize the middle, activate blood and detoxify. It has obvious effects in improving tract symptoms and improving the patient's physical signs, so that most patients have achieved good curative effect.
目前,市场上的产品多是用传统工艺制成,传统工艺常采用各种原药材粉碎成细粉(80目以上),混合后服用,而这种传统工艺在中药丸、散剂在固体类制剂中占有相当大的比例,传统的加工技术使其药物粒度多在125~180μm,不利于有效成分的充分吸收,并且具有生产成本高,药物利用率一般等不足。At present, most of the products on the market are made by traditional techniques. Traditional techniques often use various raw medicinal materials to be crushed into fine powder (above 80 mesh), and mixed before taking. However, this traditional technique is used in traditional Chinese medicine pills, powders and solid preparations. The traditional processing technology makes the drug particle size mostly 125-180 μm, which is not conducive to the full absorption of active ingredients, and has the disadvantages of high production cost and general drug utilization.
发明内容 Contents of the invention
本发明的目的是提供一种清热解毒、疏肝健脾的一种疏肝健脾中药分散片及其制备方法。The object of the present invention is to provide a Chinese medicine dispersible tablet for clearing away heat and detoxification, soothing the liver and strengthening the spleen and a preparation method thereof.
为了实现本发明的目的,本发明是通过以下技术方案实现的:一种疏肝健脾中药分散片,其特征在于:由下列原料组成:由中药提取物、填充剂、内加崩解剂、外加崩解剂、矫味剂、润湿剂、润滑剂制成,其中各种原料所占的百分比为,中药提取物10~50%、填充剂10~80%、内加崩解剂5~50%、外加崩解剂5~15%、矫味剂0.1~10%、润湿剂0.1~20%、润滑剂0.05~20%;所述的中药提取物中包括以下原料:按重量份数比为:柴胡50-70份,虎杖50-70份,黄柏30-50份,五味子90-110份,黄芪50-70份,茯苓50-70份,黄精50-70份,板蓝根90-110份,枳壳50-60份,丹参50-70份,栀子50-70份,炒白术30-50份,龙胆50-70份。In order to achieve the purpose of the present invention, the present invention is achieved through the following technical solutions: a dispersible tablet of Chinese medicine for soothing the liver and invigorating the spleen, characterized in that: it is composed of the following raw materials: a Chinese medicine extract, a filler, an internally added disintegrating agent, It is made by adding disintegrants, flavoring agents, wetting agents and lubricants. The percentages of various raw materials are as follows: 10-50% of traditional Chinese medicine extracts, 10-80% of fillers, and 5-5% of internal disintegrants. 50%, plus 5-15% disintegrating agent, 0.1-10% flavoring agent, 0.1-20% wetting agent, 0.05-20% lubricant; the Chinese medicine extract includes the following raw materials: parts by weight Ratio: Bupleurum 50-70 parts, Polygonum cuspidatum 50-70 parts, Phellodendron 30-50 parts, Schisandra 90-110 parts, Astragalus 50-70 parts, Poria cocos 50-70 parts, Polygonatum 50-70 parts, Banlangen 90-110 parts 50-60 parts of Citrus aurantii, 50-70 parts of Salvia miltiorrhiza, 50-70 parts of gardenia, 30-50 parts of fried Atractylodes macrocephala, and 50-70 parts of gentian.
所述中药提取物中原料的最佳重量份数比为:柴胡60份,虎杖60份,黄柏40份,五味子100份,黄芪60份,茯苓60份,黄精60份,板蓝根100份,枳壳40份,丹参60份,栀子60份,炒白术40份,龙胆60份。The optimal weight-to-number ratio of the raw materials in the Chinese medicine extract is: 60 parts of Bupleurum, 60 parts of Polygonum cuspidatum, 40 parts of Cortex Phellodendri, 100 parts of Schisandra chinensis, 60 parts of Astragalus membranaceus, 60 parts of Poria cocos, 60 parts of Polygonatum, 100 parts of Radix Isatidis, Hovenia citrus 40 parts of shell, 60 parts of salvia miltiorrhiza, 60 parts of gardenia, 40 parts of fried Atractylodes macrocephala, and 60 parts of gentian.
所述中药提取物10~50份、填充剂10~80份、内加崩解剂5~50份、外加崩解剂5~15份、矫味剂0.1~10份、润湿剂0.1~20份、润滑剂0.05~20份。10-50 parts of the traditional Chinese medicine extract, 10-80 parts of filler, 5-50 parts of internal disintegrating agent, 5-15 parts of external disintegrating agent, 0.1-10 parts of flavoring agent, 0.1-20 parts of wetting agent parts, lubricant 0.05 to 20 parts.
所述中药提取物40份、填充剂30份、内加崩解剂25份、外加崩解剂12份、矫味剂8份、润湿剂5份、润滑剂5份。40 parts of the traditional Chinese medicine extract, 30 parts of filler, 25 parts of internal disintegrating agent, 12 parts of external disintegrating agent, 8 parts of corrective agent, 5 parts of wetting agent and 5 parts of lubricant.
所述的填充剂可为预胶化淀粉、甘露醇、微晶纤维素、蔗糖、乳糖、氯化钠、硫酸钙其中的一种或几种的混合;所述内加崩解剂或外加崩解剂是低取代羟丙纤维素、羧甲淀粉钠、交联羧甲基纤维素钠、交联聚维酮其中的一种或几种的混合;所述矫味剂是阿司帕坦、甜菊素、枸橼酸、甜橙香精或其中的一种或几种的混合;所述的润湿剂是水、乙醇溶液中的一种或两种的混合;所述润滑剂是硬脂酸镁、十二烷基硫酸钠、二氧化硅、滑石粉其中的一种或几种的混合。The filler can be one or more of pregelatinized starch, mannitol, microcrystalline cellulose, sucrose, lactose, sodium chloride, calcium sulfate; The disintegrant is low-substituted hydroxypropyl cellulose, sodium starch glycolate, croscarmellose sodium, and crospovidone; the flavoring agent is aspartame, Stevioside, citric acid, sweet orange essence or a mixture of one or more of them; the wetting agent is a mixture of one or two of water and ethanol solution; the lubricant is stearic acid One or more of magnesium, sodium lauryl sulfate, silicon dioxide, and talc powder.
其制备方法的具体步骤为:The concrete steps of its preparation method are:
步骤1、备料:按重量份数比,选取优质的柴胡,虎杖,黄柏,五味子,黄芪,茯苓,黄精,板蓝根,枳壳,丹参,栀子,炒白术,龙胆原料,洗净并除杂;Step 1. Prepare materials: select high-quality Bupleurum bupleurum, Polygonum cuspidatum, Cortex Phellodendron, Schisandra chinensis, Astragalus membranaceus, Poria cocos, Polygonatum, Radix Isatidis, Citrus aurantium, Salvia miltiorrhiza, gardenia, fried Atractylodes macrocephala, and gentian raw materials according to the ratio of parts by weight, wash and remove miscellaneous;
步骤2:提取:按重量份数比,将上述中药,加水煎煮二次,第一次7倍量水煎煮1.5小时,第二次7倍量水煎煮1.5小时,合并两次煎液,滤除药渣和杂质,在90~95℃时,将滤液浓缩至相对密度1.1-1.3,然后冷至室温,加等量的乙醇使之沉淀,提取上清液,将上清液在温度60-65℃下,浓缩至相对密度约1.1-1.3的清膏,最后在70℃减压干燥,得提取物;Step 2: Extraction: According to the ratio of parts by weight, decoct the above-mentioned traditional Chinese medicine with water for two times, decoct in 7 times the amount of water for 1.5 hours for the first time, and decoct for 1.5 hours in 7 times the amount of water for the second time, and combine the two decoctions , filter out medicinal residues and impurities, concentrate the filtrate to a relative density of 1.1-1.3 at 90-95°C, then cool to room temperature, add an equal amount of ethanol to precipitate it, extract the supernatant, and put the supernatant at temperature At 60-65°C, concentrate to a clear paste with a relative density of about 1.1-1.3, and finally dry it under reduced pressure at 70°C to obtain the extract;
步骤3、制剂:按重量份数比,将提取物粉碎成细粉,过80目筛,然后加入填充剂、内加崩解剂混合均匀,加入润湿剂,采用流化床制粒技术制粒,制得整粒后,加入外加崩解剂、矫味剂、润滑剂混合均匀,用压片机压片,制成片剂;Step 3. Preparation: According to the ratio of parts by weight, the extract is crushed into fine powder, passed through an 80-mesh sieve, and then added with a filler and an internal disintegrant, mixed evenly, added with a wetting agent, and prepared by fluidized bed granulation technology granules, after the whole granules are prepared, add an additional disintegrant, corrective agent, and lubricant, mix evenly, and compress with a tablet machine to make tablets;
步骤4、包装:按照片剂规格,分类包装,制成成品。Step 4. Packaging: According to the specifications of the photo agent, it is sorted and packaged to make a finished product.
在上述药物中:柴胡和解表里,疏肝,升阳。治寒热往来,胸满胁痛,口苦耳聋,头痛目眩,疟疾,下利脱肛,月经不调,子宫下垂。虎杖祛风,利湿,破瘀,通经。治风湿筋骨疼痛,湿热黄疸,淋浊带下,妇女经闭,产后恶露不下,症瘕积聚,痔漏下血。跌扑损伤,烫伤,恶疮癣疾。抗心律失常和抗心肌失血活血化瘀。黄柏清热。燥湿,泻火,解毒。治热痢,泄泻,消渴,黄疸,痿躄,梦遗,淋浊,痔疮,便血,亦白带下,骨蒸劳热,目赤肿痛,口舌生疮,疮疡肿毒。五味子敛肺,滋肾,生津,收汗,涩精。治肺虚喘咳,口干作渴,自汗,盗汗,劳伤羸瘦,梦遗滑精,久泻久痢。黄芪补气固表,托毒排脓,利尿,生肌。用于气虚乏力、久泻脱肛、自汗、水肿、子官脱垂、慢性肾炎蛋白尿、糖尿病、疮口久不愈合。茯苓渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋浊,惊悸,健忘。黄精补中益气,润心肺,强筋骨。治虚损寒热,肺痨咳血,病后体虚食少,筋骨软弱,风湿疼痛,风癞癣疾。板蓝根清热,解毒,凉血。治流感,流脑,乙脑,肺炎,丹毒,热毒发斑,神昏吐衄,咽肿,痄腮,火眼,疮疹,舌绛紫暗,喉痹,烂喉丹痧,大头瘟疫,痈肿;可防治流行性乙型脑炎、急慢性肝炎、流行性腮腺炎、骨髓炎。枳壳破气,行痰,消积。治胸膈痰滞,胸痞,胁胀,食积,噫气,呕逆,下痢后重,脱肛,子宫脱垂。丹参活血祛瘀,安神宁心,排脓,止痛。治心绞痛,月经不调,痛经,经闭,血崩带下,癥瘕,积聚,瘀血腹痛,骨节疼痛,惊悸不眠,恶疮肿毒。栀子清热,泻火,凉血。治热病虚烦不眠,黄疸,淋病,消渴,目赤,咽痛,吐血,衄血,血痢,尿血,热毒疮疡,扭伤肿痛。炒白术健脾益气,燥湿利水,止汗,安胎。用于脾虚食少,腹胀泄泻,痰饮眩悸,水肿,自汗,胎动不安。龙胆泻肝胆实火,除下焦湿热。治肝经热盛,惊痫狂躁,乙型脑炎,头痛,目赤,咽痛,黄疸,热痢,痈肿疮疡,阴囊肿痛,阴部湿痒。用于湿热黄疽、阴肿阴痒、带下、湿疹瘙痒、耳聋、胁痛、口苦、惊风抽搐。Among the above-mentioned medicines: Bupleurum reconciles the exterior and interior, soothes the liver, and promotes yang. Treatment of alternating cold and heat, chest fullness and hypochondriac pain, bitter mouth and deafness, headache and dizziness, malaria, prolapse of the anus, irregular menstruation, and prolapse of the uterus. Polygonum cuspidatum dispelling wind, promoting dampness, dispelling blood stasis, promoting menstrual flow. Control rheumatism muscle and bone pain, damp-heat jaundice, stranguria turbid vaginal discharge, women's amenorrhea, postpartum lochia persistent, abdominal mass accumulation, bleeding from hemorrhoids. Injury from falls, burns, malignant sores and ringworm. Anti-arrhythmia and anti-myocardial blood loss, promoting blood circulation and removing blood stasis. Cortex Phellodendri clears away heat. Drying dampness, purging fire, detoxifying. Treatment of hot dysentery, diarrhea, thirst, jaundice, flaccidity, nocturnal emissions, stranguria, hemorrhoids, blood in the stool, leucorrhea, bone steam and heat, red eyes and swelling pain, sores on the mouth and tongue, sores and swelling. Fructus Schisandra restrains the lungs, nourishes the kidneys, produces body fluid, absorbs sweat, and astringent essence. Treatment of asthma and cough due to lung deficiency, dry mouth and thirst, spontaneous sweating, night sweats, fatigue and emaciation, nocturnal nocturnal emission, chronic diarrhea and dysentery. Radix Astragali invigorates qi and strengthens the surface, supports toxins and expels pus, diuresis, and promotes granulation. It is used for qi deficiency and fatigue, chronic diarrhea and prolapse of the anus, spontaneous sweating, edema, prolapse of the genitals, chronic nephritis, proteinuria, diabetes, and sores that do not heal for a long time. Poria wicks dampness and diuresis, benefits the spleen and stomach, calms the mind and calms the nerves. Control dysuria, edema and fullness, phlegm retention and cough, vomiting, diarrhea, spermatorrhea, stranguria, palpitations, and forgetfulness. Polygonatum invigorates the middle and replenishes Qi, moistens the heart and lungs, and strengthens the muscles and bones. Control cold and heat due to deficiency, tuberculosis and hemoptysis, physical weakness after illness, lack of food, weakness of muscles and bones, rheumatism pain, wind leprosy. Banlangen clears away heat, detoxifies, cools blood. Treatment of influenza, meningitis, Japanese encephalitis, pneumonia, erysipelas, hot spots, dizziness, vomiting, swollen throat, mumps, burning eyes, sores, dark purple tongue, sore throat, rotten throat Dansha, big head plague, carbuncle It can prevent and treat Japanese encephalitis, acute and chronic hepatitis, mumps, and osteomyelitis. Fructus Fructus Aurantii dispels qi, promotes phlegm, and eliminates stagnation. Control phlegm stagnation in the chest and diaphragm, chest fullness, hypotension, indigestion, gas, vomiting, heavy diarrhea, prolapse of the anus, and uterine prolapse. Salvia miltiorrhiza promotes blood circulation and removes blood stasis, soothes the nerves and calms the mind, drains pus, and relieves pain. Control angina pectoris, irregular menstruation, dysmenorrhea, amenorrhea, metrorrhagia, lump in the abdomen, accumulation, abdominal pain due to blood stasis, joint pain, palpitation with fear and insomnia, malignant sore and swollen toxin. Fructus Gardenia clears away heat, purifies fire, cools blood. Treatment of febrile disease, restlessness, jaundice, gonorrhea, thirst, red eyes, sore throat, hematemesis, epistaxis, dysentery, hematuria, toxic heat sores, sprains and swelling. Stir-fried Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizoma Atractylodes Rhizome is invigorating the spleen and replenishing qi, eliminating dampness and diuresis, antiperspirant, and preventing miscarriage. For insufficiency of the spleen, lack of food, abdominal distension and diarrhea, dizziness and palpitation due to phlegm and retention, edema, spontaneous sweating, restless fetal movement. Radix Gentiana purifies liver and gallbladder excess fire, and removes damp-heat in the lower burner. Control excessive heat in the liver meridian, convulsions, epilepsy and mania, Japanese encephalitis, headache, red eyes, sore throat, jaundice, dysentery, carbuncle sores, swollen and painful scrotum, and wet itching in the genitals. For damp heat jaundice, pruritus vulvae, vaginal discharge, eczema itching, deafness, hypochondriac pain, bitter mouth, convulsions and convulsions.
本发明的有益效果:本发明所述的分散片,具有清热解毒,疏肝健脾的功效,用于急、慢性肝炎,早期肝硬化的患者,其溶解性、分散性良好,溶出度高,生物利用度好,体内分布迅速,质量稳定,口感好,服用方便,可吞服,咀嚼,含吮或用水分散后服用,更适合老人和吞服困难的患者,具有药物稳定性好,包装,运输,贮藏方便等优点,其制备方法简单易行,适用于工业生产。Beneficial effects of the present invention: the dispersible tablet of the present invention has the effects of clearing heat and detoxifying, soothing the liver and invigorating the spleen, and is used for patients with acute and chronic hepatitis and early liver cirrhosis. It has good solubility and dispersibility, and high dissolution rate. Good bioavailability, rapid distribution in the body, stable quality, good taste, easy to take, can be swallowed, chewed, sucked or taken after dispersing with water, more suitable for the elderly and patients with difficulty in swallowing, with good drug stability, packaging, It has the advantages of convenient transportation and storage, and its preparation method is simple and easy, which is suitable for industrial production.
本发明经两组临床验证,其中一组为治疗组食用本发明,每天食用本发明一次,15天为一个疗程,另一组对照组使用三白草肝炎颗粒,每组选择门诊病人203例,其中男140例,女63例,最大年龄75岁,最小年龄35岁,每天使用一次,15天为一个疗程,临床表现为食欲减退、恶心、上腹部不适、肝区痛、乏力,表一为服用一个疗程后的对照数据:The present invention is clinically verified by two groups, wherein one group is the treatment group that eats the present invention, eats the present invention once a day, and 15 days is a course of treatment; Among them, there were 140 males and 63 females, the oldest was 75 years old, and the youngest was 35 years old. It was used once a day, and 15 days was a course of treatment. The clinical manifestations were loss of appetite, nausea, upper abdominal discomfort, liver pain, and fatigue. Table 1 shows Control data after taking a course of treatment:
表1服用前后两组疗程比较(单位:人)Table 1 Comparison of two groups of courses of treatment before and after taking (unit: person)
治疗组和对照组有显著差异,从而可以看出本发明在临床上的应用有显著的疗效。There is a significant difference between the treatment group and the control group, so it can be seen that the clinical application of the present invention has a significant curative effect.
本发明的工艺特点:1、选择原料科学,生产工艺先进,其产品方便存放和使用;2、产品中药物成分易被人体吸收;3、原料来源广泛,加工艺线路短,产品易加工制造。The process characteristics of the present invention: 1. Scientific selection of raw materials, advanced production technology, and convenient storage and use of the product; 2. The medicinal ingredients in the product are easily absorbed by the human body; 3. Wide source of raw materials, short processing line, and easy processing and manufacturing of the product.
具体实施方式:Detailed ways:
实施例1Example 1
一种疏肝健脾中药分散片,其特征在于:由下列原料组成:由中药提取物、填充剂、内加崩解剂、外加崩解剂、矫味剂、润湿剂、润滑剂制成,其中各种原料所占的百分比为,中药提取物10~50%、填充剂10~80%、内加崩解剂5~50%、外加崩解剂5~15%、矫味剂0.1~10%、润湿剂0.1~20%、润滑剂0.05~20%;所述的中药提取物中包括以下原料:按重量份数比为:柴胡50-70份,虎杖50-70份,黄柏30-50份,五味子90-110份,黄芪50-70份,茯苓50-70份,黄精50-70份,板蓝根90-110份,枳壳50-60份,丹参50-70份,栀子50-70份,炒白术30-50份,龙胆50-70份。A dispersible tablet of traditional Chinese medicine for soothing the liver and invigorating the spleen, characterized in that it is composed of the following raw materials: it is made of Chinese medicine extract, filler, internally added disintegrating agent, externally added disintegrating agent, corrective agent, wetting agent and lubricant , wherein the percentages of various raw materials are: Chinese medicine extract 10-50%, filler 10-80%, internal disintegrant 5-50%, external disintegrant 5-15%, flavoring agent 0.1- 10%, wetting agent 0.1-20%, lubricant 0.05-20%; the Chinese medicine extract includes the following raw materials: by weight: Bupleurum 50-70 parts, Polygonum cuspidatum 50-70 parts, Cortex Phellodendri 30-50 parts, Schisandra 90-110 parts, Astragalus 50-70 parts, Poria cocos 50-70 parts, Polygonatum 50-70 parts, Radix Radix 90-110 parts, Citrus aurantium 50-60 parts, Salvia miltiorrhiza 50-70 parts, gardenia 50-70 parts, 30-50 parts of fried Atractylodes macrocephala, and 50-70 parts of gentian.
所述中药提取物中原料的最佳重量份数比为:柴胡60份,虎杖60份,黄柏40份,五味子100份,黄芪60份,茯苓60份,黄精60份,板蓝根100份,枳壳40份,丹参60份,栀子60份,炒白术40份,龙胆60份。The optimal weight-to-number ratio of the raw materials in the Chinese medicine extract is: 60 parts of Bupleurum, 60 parts of Polygonum cuspidatum, 40 parts of Cortex Phellodendri, 100 parts of Schisandra chinensis, 60 parts of Astragalus membranaceus, 60 parts of Poria cocos, 60 parts of Polygonatum, 100 parts of Radix Isatidis, Hovenia citrus 40 parts of shell, 60 parts of salvia miltiorrhiza, 60 parts of gardenia, 40 parts of fried Atractylodes macrocephala, and 60 parts of gentian.
所述中药提取物10~50份、填充剂10~80份、内加崩解剂5~50份、外加崩解剂5~15份、矫味剂0.1~10份、润湿剂0.1~20份、润滑剂0.05~20份。10-50 parts of the traditional Chinese medicine extract, 10-80 parts of filler, 5-50 parts of internal disintegrating agent, 5-15 parts of external disintegrating agent, 0.1-10 parts of flavoring agent, 0.1-20 parts of wetting agent parts, lubricant 0.05 to 20 parts.
所述中药提取物40份、填充剂30份、内加崩解剂25份、外加崩解剂12份、矫味剂8份、润湿剂5份、润滑剂5份。40 parts of the traditional Chinese medicine extract, 30 parts of filler, 25 parts of internal disintegrating agent, 12 parts of external disintegrating agent, 8 parts of corrective agent, 5 parts of wetting agent and 5 parts of lubricant.
所述的填充剂可为预胶化淀粉、甘露醇、微晶纤维素、蔗糖、乳糖、氯化钠、硫酸钙其中的一种或几种的混合;所述内加崩解剂或外加崩解剂是低取代羟丙纤维素、羧甲淀粉钠、交联羧甲基纤维素钠、交联聚维酮其中的一种或几种的混合;所述矫味剂是阿司帕坦、甜菊素、枸橼酸、甜橙香精或其中的一种或几种的混合;所述的润湿剂是水、乙醇溶液中的一种或两种的混合;所述润滑剂是硬脂酸镁、十二烷基硫酸钠、二氧化硅、滑石粉其中的一种或几种的混合。The filler can be one or more of pregelatinized starch, mannitol, microcrystalline cellulose, sucrose, lactose, sodium chloride, calcium sulfate; The disintegrant is low-substituted hydroxypropyl cellulose, sodium starch glycolate, croscarmellose sodium, and crospovidone; the flavoring agent is aspartame, Stevioside, citric acid, sweet orange essence or a mixture of one or more of them; the wetting agent is a mixture of one or two of water and ethanol solution; the lubricant is stearic acid One or more of magnesium, sodium lauryl sulfate, silicon dioxide, and talc powder.
其制备方法的具体步骤为:The concrete steps of its preparation method are:
步骤1、备料:按重量份数比,选取优质的柴胡,虎杖,黄柏,五味子,黄芪,茯苓,黄精,板蓝根,枳壳,丹参,栀子,炒白术,龙胆原料,洗净并除杂;Step 1. Prepare materials: select high-quality Bupleurum bupleurum, Polygonum cuspidatum, Cortex Phellodendron, Schisandra chinensis, Astragalus membranaceus, Poria cocos, Polygonatum, Radix Isatidis, Citrus aurantium, Salvia miltiorrhiza, gardenia, fried Atractylodes macrocephala, and gentian raw materials according to the ratio of parts by weight, wash and remove miscellaneous;
步骤2:提取:按重量份数比,将上述中药,加水煎煮二次,第一次7倍量水煎煮1.5小时,第二次7倍量水煎煮1.5小时,合并两次煎液,滤除药渣和杂质,在90~95℃时,将滤液浓缩至相对密度1.1-1.3,然后冷至室温,加等量的乙醇使之沉淀,提取上清液,将上清液在温度60-65℃下,浓缩至相对密度约1.1-1.3的清膏,最后在70℃减压干燥,得提取物;Step 2: Extraction: According to the ratio of parts by weight, decoct the above-mentioned traditional Chinese medicine with water for two times, decoct in 7 times the amount of water for 1.5 hours for the first time, and decoct for 1.5 hours in 7 times the amount of water for the second time, and combine the two decoctions , filter out medicinal residues and impurities, concentrate the filtrate to a relative density of 1.1-1.3 at 90-95°C, then cool to room temperature, add an equal amount of ethanol to precipitate it, extract the supernatant, and put the supernatant at temperature At 60-65°C, concentrate to a clear paste with a relative density of about 1.1-1.3, and finally dry it under reduced pressure at 70°C to obtain the extract;
步骤3、制剂:按重量份数比,将提取物粉碎成细粉,过80目筛,然后加入填充剂、内加崩解剂混合均匀,加入润湿剂,采用流化床制粒技术制粒,制得整粒后,加入外加崩解剂、矫味剂、润滑剂混合均匀,用压片机压片,制成片剂;Step 3. Preparation: According to the ratio of parts by weight, the extract is crushed into fine powder, passed through an 80-mesh sieve, and then added with a filler and an internal disintegrant, mixed evenly, added with a wetting agent, and prepared by fluidized bed granulation technology granules, after the whole granules are prepared, add an additional disintegrant, corrective agent, and lubricant, mix evenly, and compress with a tablet machine to make tablets;
步骤4、包装:按照片剂规格,分类包装,制成成品。Step 4. Packaging: According to the specifications of the photo agent, it is sorted and packaged to make a finished product.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410688245.8A CN104435710A (en) | 2014-11-26 | 2014-11-26 | A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410688245.8A CN104435710A (en) | 2014-11-26 | 2014-11-26 | A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104435710A true CN104435710A (en) | 2015-03-25 |
Family
ID=52882971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410688245.8A Pending CN104435710A (en) | 2014-11-26 | 2014-11-26 | A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104435710A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105381040A (en) * | 2015-11-19 | 2016-03-09 | 哈尔滨圣吉药业股份有限公司 | A kind of Hegan Lidan dispersible tablet and preparation method thereof |
CN106728983A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of fibert strengthening the spleen and stomach electuary and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
AU6295196A (en) * | 1995-07-10 | 1997-02-10 | Cathay Herbal Laboratories Pty Ltd | Herbal compositions for hepatic disorders |
CN1253830A (en) * | 1999-12-06 | 2000-05-24 | 黄培乐 | Chinese medicine prescription for curing hepatitis, cholangitis, pancreatitis and cirrhosis |
CN1385191A (en) * | 2002-06-04 | 2002-12-18 | 徐连豪 | Medicine for treating liver disease |
CN101513488A (en) * | 2009-04-02 | 2009-08-26 | 田家全 | Traditional Chinese medicine compound for treating hepatitis |
CN102389496A (en) * | 2011-11-16 | 2012-03-28 | 蚌埠丰原涂山制药有限公司 | Chinese medical composition for treating hepatitis and preparation method thereof |
CN103285156A (en) * | 2013-06-06 | 2013-09-11 | 宋艳红 | Medicament for treating hepatopathy |
-
2014
- 2014-11-26 CN CN201410688245.8A patent/CN104435710A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1113779A (en) * | 1994-06-17 | 1995-12-27 | 殷广全 | Anti- hepatitis B preparation |
AU6295196A (en) * | 1995-07-10 | 1997-02-10 | Cathay Herbal Laboratories Pty Ltd | Herbal compositions for hepatic disorders |
CN1253830A (en) * | 1999-12-06 | 2000-05-24 | 黄培乐 | Chinese medicine prescription for curing hepatitis, cholangitis, pancreatitis and cirrhosis |
CN1385191A (en) * | 2002-06-04 | 2002-12-18 | 徐连豪 | Medicine for treating liver disease |
CN101513488A (en) * | 2009-04-02 | 2009-08-26 | 田家全 | Traditional Chinese medicine compound for treating hepatitis |
CN102389496A (en) * | 2011-11-16 | 2012-03-28 | 蚌埠丰原涂山制药有限公司 | Chinese medical composition for treating hepatitis and preparation method thereof |
CN103285156A (en) * | 2013-06-06 | 2013-09-11 | 宋艳红 | Medicament for treating hepatopathy |
Non-Patent Citations (4)
Title |
---|
姚静: "《药用辅料应用指南》", 31 August 2011, 北京:中国医药科技出版社 * |
宋明臣: "中药"乙肝灵冲剂"治疗乙型肝炎疗效观察", 《黑龙江中医药》 * |
程运友: "解毒治本汤治疗慢性乙型肝炎30例观察", 《实用中医药杂志》 * |
陈洪轩: "《药剂辅料实用技术》", 31 August 2001, 开封:河南大学出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105381040A (en) * | 2015-11-19 | 2016-03-09 | 哈尔滨圣吉药业股份有限公司 | A kind of Hegan Lidan dispersible tablet and preparation method thereof |
CN106728983A (en) * | 2015-11-19 | 2017-05-31 | 哈尔滨圣吉药业股份有限公司 | A kind of fibert strengthening the spleen and stomach electuary and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100586468C (en) | A kind of traditional Chinese medicine for treating hepatitis B | |
CN105477616A (en) | Medicine for easing mental anxiety, reducing phlegm, restoring consciousness and promoting blood circulation to remove meridian obstruction and preparation method thereof | |
CN104352757A (en) | A kind of dispersible tablet of traditional Chinese medicine for invigorating the kidney and invigorating the spleen and its preparation method | |
CN106511864A (en) | Traditional Chinese medicine composition and preparation method and applications thereof in treatment of cervical carcinoma | |
CN104922639A (en) | Traditional Chinese medicine stomach-nourishing pill and preparation method thereof | |
CN104435710A (en) | A traditional Chinese medicine dispersible tablet for soothing the liver and invigorating the spleen and its preparation method | |
CN103520571B (en) | Traditional Chinese medicine for treating qi stagnation and blood stasis syndrome type abdominal mass diseases | |
CN103301337B (en) | Traditional Chinese medicine for treating bovine puerperal fever | |
CN104667185A (en) | Traditional Chinese medicine tablet for treating refractory insomnia | |
CN103690869B (en) | Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof | |
CN106177542A (en) | The Chinese prescription of a kind of summer heat clearing toxin resolving and goods thereof | |
CN105521332A (en) | Traditional Chinese medicinal composition for treating anal fissure, and preparation method and application thereof | |
CN105878850A (en) | Drug pills for treating heart-blood deficiency disease and preparation method thereof | |
CN104436044A (en) | A kind of traditional Chinese medicine dispersible tablet for treating coronary heart disease and preparation method thereof | |
CN104435138A (en) | Paishi traditional Chinese medicine dispersible tablet and preparation method thereof | |
CN104383414A (en) | Formula of traditional Chinese medicine for treating gastric carcinoma | |
CN103536863B (en) | A kind of Chinese medicine for the treatment of the infertile disease of obstruction of collaterals by blood stasis pattern of syndrome | |
CN117244035B (en) | Pharmaceutical composition for treating breast nodules and preparation method thereof | |
CN103655846B (en) | Traditional Chinese medicine for treating gastric collateral stasis syndrome type gastroptosis | |
CN104547706A (en) | Pharmaceutical composition for treating cough with lung heat, as well as preparation method thereof | |
CN105250618A (en) | Antiviral traditional Chinese medicine composition for treating liver cirrhosis and preparation method thereof | |
CN105688074A (en) | Decoction medicine for treating hypogastric pain and preparation method of decoction medicine | |
CN104840757A (en) | Traditional Chinese medicine preparation for alleviating dysmenorrheal and preparation method | |
CN104623385A (en) | Pharmaceutical compound for treating mammary gland hyperplasia and preparation method of pharmaceutical compound | |
CN103536892A (en) | Traditional Chinese medicine for treating infertility of syndrome of yang deficiency and coagulated cold |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20150325 |